DIPNA PHARMACHEM LTD.
Market Cap.(`)
|
30.25 Cr.
|
P/BV
|
0.81
|
Book Value (`)
|
15.60
|
52 Week High/Low ( ` )
|
17/6
|
FV/ML
|
10/3000
|
P/E(X)
|
27.89
|
Book Closure
|
27/08/2024
|
EPS (`)
|
0.45
|
Div Yield (%)
|
0.00
|
You can view the Standalone
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 0.90 | 260.55 | 333.40 | 6.91 | 16.86 |
Diluted EPS (Rs.) | 0.90 | 260.55 | 333.40 | 6.91 | 16.86 |
Cash EPS (Rs.) | 0.45 | 0.77 | 335.17 | 8.97 | 19.37 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 15.60 | 20.35 | 496.74 | 163.34 | 156.41 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 15.60 | 20.35 | 496.74 | 163.34 | 156.41 |
Revenue From Operations / Share (Rs.) | 68.34 | 83.48 | 20787.26 | 8857.11 | 8725.29 |
PBDIT / Share (Rs.) | 1.43 | 1.96 | 644.23 | 118.66 | 92.26 |
PBIT / Share (Rs.) | 1.42 | 1.95 | 642.46 | 116.60 | 89.75 |
PBT / Share (Rs.) | 0.59 | 1.15 | 449.80 | 15.71 | 17.15 |
Net Profit / Share (Rs.) | 0.45 | 0.76 | 333.40 | 6.91 | 16.86 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 2.08 | 2.35 | 3.09 | 1.33 | 1.05 |
PBIT Margin (%) | 2.07 | 2.33 | 3.09 | 1.31 | 1.02 |
PBT Margin (%) | 0.86 | 1.38 | 2.16 | 0.17 | 0.19 |
Net Profit Margin (%) | 0.66 | 0.91 | 1.60 | 0.07 | 0.19 |
Return on Networth / Equity (%) | 2.89 | 3.74 | 67.11 | 4.23 | 10.78 |
Return on Capital Employeed (%) | 6.82 | 6.06 | 44.39 | 9.58 | 57.38 |
Return On Assets (%) | 0.81 | 1.17 | 3.22 | 0.09 | 0.32 |
Long Term Debt / Equity (X) | 0.33 | 0.58 | 1.91 | 6.44 | 0.00 |
Total Debt / Equity (X) | 0.51 | 0.65 | 5.86 | 21.74 | 17.45 |
Asset Turnover Ratio (%) | 1.56 | 1.76 | 2.38 | 1.43 | 1.88 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.60 | 1.99 | 1.16 | 1.21 | 1.03 |
Quick Ratio (X) | 1.15 | 1.50 | 0.95 | 0.85 | 0.71 |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 10.03 | 4.90 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 1.72 | 2.46 | 3.34 | 1.18 | 1.27 |
Interest Coverage Ratio (Post Tax) (%) | 1.54 | 1.95 | 2.73 | 1.07 | 1.23 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 28.22 | 25.24 | 0.00 | 0.00 | 0.00 |
EV / Net Operating Revenue (X) | 0.17 | 0.25 | 0.00 | 0.00 | 0.00 |
EV / EBITDA (X) | 8.22 | 10.74 | 0.00 | 0.00 | 0.00 |
MarketCap / Net Operating Revenue (X) | 0.13 | 0.15 | 0.00 | 0.00 | 0.00 |
Price / BV (X) | 0.60 | 0.61 | 0.00 | 0.00 | 0.00 |
Price / Net Operating Revenue (X) | 0.13 | 0.15 | 0.00 | 0.00 | 0.00 |
EarningsYield | 0.04 | 0.06 | 0.00 | 0.00 | 0.00 |